Psilocybin for Depression, MDMA for PTSD: What Phase 3 Trials Show
Media coverage of psychedelics outpaces the trial evidence. MDMA-PTSD signals are large; psilocybin-depression effects shrink against active comparators.
psychedelics
Are Mystical Experiences Required for the Antidepressant Effects of Ketamine & Psychedelics?
The intersection of mental health treatment and pharmacology is witnessing a remarkable shift with the growing interest in ketamine and classic psychedelics like psilocybin for their rapid and sustained antidepressant effects. Unlike traditional antidepressants, these substances offer hope for those with treatment-resistant depression by potentially transforming treatment paradigms. However, it remains somewhat unclear as to …
Effects of DMT on Mental Health: Depression & Anxiety in Healthy Adults (2024 Study)
In the quest for innovative treatments for psychiatric disorders, the study of psychedelics has taken a significant leap forward. Among these, Dimethyltryptamine (DMT), known for its rapid onset and short duration of action, emerges as a compelling alternative to traditional therapies. Recent studies have begun to explore its potential, particularly in treating depression and anxiety, …
Psychedelics vs. Epilepsy & Seizures: Effective Treatment or Exacerbation? (2023 Review)
Psychedelic compounds, long associated with the fringes of medicine and spirituality, are now at the forefront of a radical shift in neurology and psychiatry. Decades of clinical trials have begun to unravel the therapeutic potentials of these substances, revealing promising outcomes in the treatment of various psychiatric disorders. However, a notable gap in this burgeoning …
Low Dose LSD for Depression Treatment: Preliminary Efficacy (2023 Study)
Recent research exploring the use of low doses of LSD (Lysergic acid diethylamide) in treating depression marks a significant shift in the psychiatric landscape. This innovative approach seeks to understand and harness the potential therapeutic benefits of psychedelics, which were once stigmatized and largely overlooked in clinical settings. Highlights: Study Design: The research employed a …
Psychedelics for Depression: Targeting the 5-HT2A Receptor & Beyond (2023 Study)
The quest for effective treatments for Major Depressive Disorder (MDD) has taken a revolutionary turn with the exploration of psychedelic compounds. Recent research has evaluated the potential of substances like psilocybin and lisuride, offering new hope for patients unresponsive to traditional antidepressants. Highlights: Traditional Limitations: Standard antidepressants often fail to provide relief for 30% of …
Testing LSD For Anxiety In Terminal Cancer Patients
People with life-threatening, terminal forms of cancer are subject to high levels of anxiety. Generally this stems from the awareness that death could be an imminent possibility. Many researchers have focused on how to increase the quality of life among individuals with terminal cancer prior to their passing and specifically focused on addressing levels of anxiety …